JPS6320205B2 - - Google Patents
Info
- Publication number
- JPS6320205B2 JPS6320205B2 JP54150363A JP15036379A JPS6320205B2 JP S6320205 B2 JPS6320205 B2 JP S6320205B2 JP 54150363 A JP54150363 A JP 54150363A JP 15036379 A JP15036379 A JP 15036379A JP S6320205 B2 JPS6320205 B2 JP S6320205B2
- Authority
- JP
- Japan
- Prior art keywords
- pantethine
- whitening
- general formula
- cosmetic
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
本発明は美白化粧料、更に詳しくはパンテチン
またはそのアシル化誘導体の少なくとも一方を配
合してなる美白化粧料に関するものである。
従来、パンテチンは、その前駆物質であるパン
トテン酸の生体内反応の結果としてパンテテイン
と共に生体内にその存在が認められ、還元されて
パンテテインとしてアセチル補酵素、アセチルキ
ヤリヤープロテインの構成々分となり、炭水化物
代射、脂肪酸分解、合成等に関与するなどの広い
生理作用を有するとされている。このパンテチン
については最近その薬理効果が注目視され、脂肪
代謝におよぼす影響や動脈硬化の予防あるいは修
復作用が解明されつゝある現状にあるが、未だ化
粧料に具体的に応用された例は皆無と云つてよ
い。
一方、美白効果を得る目的で化粧料に配合され
てきた物質としては、かねてよりアスコルビン酸
(含誘導体)、過酸化水素、グルタチオン、コロイ
ド硫黄等や各種天然物が知られているが、アスコ
ルビン酸は湿性化粧料の如き水分を多く含む系に
おいては酸化されやすく不安定であり、変色、変
臭の原因となりがちである。過酸化水素について
は過酸化物と云う特性上、保存面、安定性面から
充分なものとは云い難い。グルタチオンやコロイ
ド硫黄は著しい異臭を放つため化粧料へ使用する
ことは避けられている。また天然物については効
果の確認されたものは殆んどなく、しかも前記の
各物質と同様に皮膚に対する美白作用は充分に満
足すべきものではない。
そこで、本発明者は前記の状況に鑑み、パンテ
チンならびにそのアシル化誘導体について鋭意研
究した結果、これらを化粧料基剤に配合し皮膚に
塗布すると、非常に少量の配合下にあつても、前
駆物質であるパントテン酸を含めて従来全く知ら
れていなかつた効果、すなわちチロシナーゼ活性
阻害およびメラニン色素脱色作用に基づく著しい
美白効果のあることを見出し、本発明の完成に至
つた。
すなわち、本発明は下記一般式()で示され
るパンテチンおよび/または一般式()で示さ
れるパンテチンアシル化誘導体を化粧量全体に対
して0.01〜1重量%の範囲で配合することを特徴
とする美白化粧料に関し、上記公知の美白物質で
は得られない極めて優れた効果を有する美白化粧
料を提供せんとするものである。
一般式()
一般式()
(式中、R1,R2,R3,R4は、すべて水素原子
又はすべてアシル基の場合を除くことを条件とし
て、少なくとも一つが炭素数2から10の直鎖また
は分岐鎖のアシル基でその他は水素原子を表わ
す。)
以下、本発明を詳細に説明する。
本発明に適用されるパンテチンは上記一般式
()で示されるもので、所謂パンテテインの2
分子が末端のメルカプト基どうしの間でジスルフ
イド結合して生ずる物質であつて、これを得る方
法としては例えば特公昭41―2896号、特公昭44―
3324号などに見られるような前駆物質であるパン
トテン酸(塩)を出発物質とする合成法、コエン
チームAを単離する方法その他種々の方法があ
る。
同様に、パンテチンアシル化誘導体としては前
記一般式()に示されたもので、これはパンテ
チンに対するシヨシテン―バウマン反応などの通
常のアシル化反応により容易に得ることができ
る。パンテチンアシル化誘導体の具体例として
は、モノブタノイルパンテチン、ジプロピオロイ
ルパンテチン、ジブタノイルパンテチン、ジカプ
ロイルパンテチン、ジペラルゴノイルパンテチ
ン、トリカプリロイルパンテチン、トリ―2―エ
チルヘキサノイルパンテチン、トリデカノイルパ
ンテチンなどの一般式()中のアシル基が炭素
数2〜10のものが挙げられ、これらは各種化粧料
剤型に応じて適宜選択するものであり、化粧水の
如き水性化粧料の場合はアシル基が炭素数2〜6
のもの好ましくはモノブタノイルパンテチン、ジ
プロピオロイルパンテチン等、化粧クリームの如
き油性化粧料の場合は炭素数8〜10のもの好まし
くはジペラルゴノイルパンテチン、トリ―2―エ
チルヘキサノイルパンテチン等である。
次に、本発明に適用されるパンテチンアシル化
誘導体の合成例を示す。
合成例1 ジブタノイルパンテチン
パンテチン11g、トリエチルアミン4.5gをジ
メチルホルムアミド(DMF)50mlに溶解し、氷
冷下、5.5gの酪酸クロライドを溶解したテトラ
ヒドロフラン(THF)液30mlを滴下し反応させ
た。更に室温下で2時間反応させた後、脱溶媒
し、酢酸エチルで抽出した。抽出物をシリカゲル
カラムに展開し、傾斜法(クロロホルム→クロロ
ホルム:メチノール=8:2)で分画精製し、粘
稠液状のジブタノイルパンテチン7.8gを得た。
Γ NMR(δ値)2.9(CH2 ―S―S―CH2 )、
4.0(COOCH2 )
The present invention relates to a whitening cosmetic, and more particularly to a whitening cosmetic containing at least one of pantethine or its acylated derivative. Conventionally, pantethine has been found to exist in the body together with pantetheine as a result of the in-vivo reaction of its precursor pantothenic acid, and is reduced to form pantetheine, a component of acetyl coenzyme and acetyl carrier protein, and is converted into carbohydrates. It is said to have a wide range of physiological actions, including being involved in direct injection, fatty acid decomposition, synthesis, etc. Pantethine has recently attracted attention for its pharmacological effects, and its effects on fat metabolism and prevention and repair effects on arteriosclerosis are currently being elucidated, but there have been no examples of its specific application in cosmetics yet. You can say that. On the other hand, ascorbic acid (derivatives), hydrogen peroxide, glutathione, colloidal sulfur, and various other natural products have long been known as substances that have been added to cosmetics for the purpose of achieving a whitening effect. is easily oxidized and unstable in systems containing a large amount of water, such as wet cosmetics, and tends to cause discoloration and odor. Due to the characteristics of hydrogen peroxide, it is difficult to say that it is sufficient in terms of storage and stability. Glutathione and colloidal sulfur are avoided in cosmetics because they emit a distinct odor. Furthermore, there are almost no natural products whose effects have been confirmed, and like the above-mentioned substances, their whitening effect on the skin is not fully satisfactory. Therefore, in view of the above situation, the present inventor conducted extensive research on pantethine and its acylated derivatives, and found that when these are blended into a cosmetic base and applied to the skin, even when a very small amount is blended, the precursor The present inventors have discovered that the substance pantothenic acid has a previously unknown effect, that is, a remarkable whitening effect based on tyrosinase activity inhibition and melanin pigment bleaching action, leading to the completion of the present invention. That is, the present invention is characterized in that pantethine represented by the following general formula () and/or pantethine acylated derivative represented by the general formula () is blended in an amount of 0.01 to 1% by weight based on the total cosmetic amount. Regarding whitening cosmetics, it is an object of the present invention to provide whitening cosmetics that have extremely excellent effects that cannot be obtained with the above-mentioned known whitening substances. General formula () General formula () (In the formula, at least one of R 1 , R 2 , R 3 , and R 4 is a linear or branched acyl group having 2 to 10 carbon atoms, unless all are hydrogen atoms or all acyl groups.) and the others represent hydrogen atoms.) The present invention will be described in detail below. Pantethine applied to the present invention is represented by the above general formula (), and is the so-called 2 of pantethine.
It is a substance produced by disulfide bonding between mercapto groups at the end of the molecule, and methods for obtaining it include, for example, Japanese Patent Publication No. 41-2896, Japanese Patent Publication No. 44-
There are various methods such as a synthesis method using pantothenic acid (salt) as a precursor as a starting material as seen in No. 3324, a method of isolating coenzyme A, and others. Similarly, the acylated pantethine derivative is represented by the general formula (), which can be easily obtained by a conventional acylation reaction of pantethine, such as the Syoshiten-Baumann reaction. Specific examples of pantethine acylated derivatives include monobutanoylpantethine, dipropioloylpantethine, dibutanoylpantethine, dicaproylpantethine, dipelargoylpantethine, tricapryloylpantethine, tri-2-ethylhexanoylpantethine, and tri-2-ethylhexanoylpantethine. Examples include those in which the acyl group in the general formula () has 2 to 10 carbon atoms, such as decanoylpantethine, and these are selected appropriately depending on the type of various cosmetic formulations, and are suitable for aqueous cosmetics such as lotions. If the acyl group has 2 to 6 carbon atoms
Preferably monobutanoyl pantethine, dipropioloyl pantethine, etc.; in the case of oil-based cosmetics such as cosmetic creams, those having 8 to 10 carbon atoms, preferably dipelargonoyl pantethine, tri-2-ethylhexanoyl pantethine, etc. . Next, a synthesis example of a pantethine acylated derivative applied to the present invention will be shown. Synthesis Example 1 Dibutanoylpantethine 11 g of pantethine and 4.5 g of triethylamine were dissolved in 50 ml of dimethylformamide (DMF), and under ice cooling, 30 ml of a tetrahydrofuran (THF) solution in which 5.5 g of butyric acid chloride was dissolved was added dropwise to react. After further reacting at room temperature for 2 hours, the solvent was removed and extracted with ethyl acetate. The extract was developed on a silica gel column and fractionated and purified using a gradient method (chloroform→chloroform:methinol=8:2) to obtain 7.8 g of dibutanoylpantethine in the form of a viscous liquid. Γ NMR (δ value) 2.9 (C H 2 -S-S-C H 2 ),
4.0 ( COOCH2 )
【式】7.3(CONH)
Γ 元素分析値(C30H54N4O10S2として)
分析値(%)C51.58,H8.01,N8.10
計算値(%)C51.85,H7.33,N8.06
合成例2 トリ―2―エチルヘキサノイルパンテ
チン
パンテチン22gをピリジン150mlに溶解し、こ
れり氷冷下、2―エチルヘキサン酸クロライド22
gを溶解したベンゼン液100mlを滴下し反応させ
た。更に室温下で3時間反応させた後、脱溶媒
し、酢酸エチルで抽出した。抽出物をシリカゲル
カラムに展開し、n―ヘキサン:エチルエーテル
=1:1で脂肪酸を溶出させた後、n―ヘキサ
ン:エタノール=85:15で分画精製して、粘稠液
状のトリ―2―エチルヘキサノイルパンテチン
23.4gを得た。
Γ 元素分析値(C46H84N4O11S2として)
分析値(%)C59.42,H8.92,N5.98
計算値(%)C59.20,H9.07,N6.00
本発明の美白化粧料では、前記したパンテチン
またはパンテチンアシル化誘導体が化粧料全体に
対して0.01〜1重量%好ましくは0.05〜1重量%
の範囲で配合される。0.01重量%より少ない量で
は皮膚に対し美白化粧料を塗布しても、経皮吸収
量が美白効果を発現する至適量とならず、反対に
1重量%を越える量を用いた場合、化粧料基剤と
の相溶性の関係から例えばローシヨン系ではオリ
の発生を生ずるなどの不都合を生じ、また個人差
はあるが過度のチロシナーゼ活性阻害による不自
然な脱色効果を与えやすい(この傾向は特に5重
量%以上の場合に顕著となる。)ことから避ける
べきである。
上記パンテチン、パンテチンアシル化誘導体を
化粧料基剤に配合する場合には、これらを単独で
あるいは併用しても、またその他の還元性美白物
質と共に用いてもよいが、本来パンテチンそのも
のは水溶性であり、酸化に対する化学的な安定性
を損いやすいとう点から、実際の系への使用にお
いては、抗酸化性の物質と共に用いるか、これよ
りかなり安定であるパンテチンアシル化誘導体に
するか、又はこれとの併用に留意すべきである。
本発明の重要な点の一つはパンテチンに由来する
効果を充分に発揮させるために、上記の如くパン
テチンの誘導体化を行ない安定化を図つたことに
ある。
次に、本発明の美白化粧料に適用されるパンテ
チンならびにパンテチンアシル化誘導体が如何に
美白効果の点で優れているかを実証するため、そ
の機序として知られているチロシナーゼ活性阻害
作用について行なつた試験結果を示す。
(方法)
ハーデイングパツセイ(Harding―Passay)
マウスメラノーマから抽出した酵素チロシナーゼ
を使用し、その酵素活性をドーパークロームの
475nmの吸光度を測定するフオトメトリー法で行
なつた。試験物質としては、本発明に係るパンテ
チンならびにパンテチンアシル化誘導体の一つで
あるジブタノイルパンテチンと比較品としてパン
テチンの前駆物質であるパントテン酸カルシウム
およびパンテチンと同種のジスルフイド結合(―
S―S―)を有する酸化型グルタチオンとを用い
た。各種試料の5×10-5molとマウス肝ホモジネ
ートをインキユベーシヨンした反応液をチロシナ
ーゼ阻害マツセイ系に添加し、肝ホモジネートの
みの場合を対照に、阻害率を測定した。その結果
を第1表に示す。[Formula] 7.3 (CON H ) Γ Elemental analysis value (as C 30 H 54 N 4 O 10 S 2 ) Analysis value (%) C51.58, H8.01, N8.10 Calculated value (%) C51.85, H7.33, N8.06 Synthesis Example 2 Tri-2-ethylhexanoylpantethine Dissolve 22g of pantethine in 150ml of pyridine, cool on ice, and prepare 2-ethylhexanoyl chloride 22
100 ml of a benzene solution in which g was dissolved was added dropwise to cause a reaction. After further reacting at room temperature for 3 hours, the solvent was removed and extracted with ethyl acetate. The extract was developed on a silica gel column, fatty acids were eluted with n-hexane: ethyl ether = 1:1, and then fractionated and purified with n-hexane: ethanol = 85:15 to obtain a viscous liquid tri-2. -Ethylhexanoylpantethine
23.4g was obtained. Γ Elemental analysis value (as C 46 H 84 N 4 O 11 S 2 ) Analysis value (%) C59.42, H8.92, N5.98 Calculated value (%) C59.20, H9.07, N6.00 pieces In the whitening cosmetic composition of the invention, the above-mentioned pantethine or pantethine acylated derivative is contained in an amount of 0.01 to 1% by weight, preferably 0.05 to 1% by weight, based on the total cosmetic composition.
It is blended within the range of. If the amount is less than 0.01% by weight, even if the whitening cosmetic is applied to the skin, the amount absorbed through the skin will not be the optimal amount to produce the whitening effect.On the other hand, if the amount is more than 1% by weight, the cosmetic Due to the compatibility with the base, for example, lotion systems may cause problems such as the formation of crusts, and although it varies from person to person, they tend to give an unnatural decolorizing effect due to excessive inhibition of tyrosinase activity (this tendency is particularly true for lotion systems). % by weight or more) and should therefore be avoided. When the above-mentioned pantethine and pantethine acylated derivatives are incorporated into a cosmetic base, they may be used alone or in combination, or with other reducing whitening substances, but pantethine itself is originally water-soluble. However, since it tends to impair chemical stability against oxidation, when used in actual systems, it is necessary to use it together with an antioxidant substance, or to use a pantethine acylated derivative, which is considerably more stable. Care should be taken when used in combination with
One of the important points of the present invention is that in order to fully exhibit the effects derived from pantethine, pantethine is derivatized and stabilized as described above. Next, in order to demonstrate how superior pantethine and pantethine acylated derivatives applied to the whitening cosmetics of the present invention are in terms of whitening effects, we investigated the tyrosinase activity inhibition effect, which is known as its mechanism. The test results are shown below. (Method) Harding-Passay
Using the enzyme tyrosinase extracted from mouse melanoma, its enzyme activity was expressed in Doperchrome.
The photometry method was used to measure absorbance at 475 nm. The test substances include pantethine according to the present invention, dibutanoylpantethine, which is one of the acylated derivatives of pantethine, calcium pantothenate, which is a precursor of pantethine, and disulfide bonds (--
An oxidized glutathione having an oxidized form of glutathione (S—S—) was used. A reaction solution obtained by incubating 5×10 −5 mol of each sample with mouse liver homogenate was added to a tyrosinase inhibition system, and the inhibition rate was measured using liver homogenate alone as a control. The results are shown in Table 1.
【表】
第1表の結果に示された如く、パンテチンの前
駆物質であるパントテン酸カルシウムならびにジ
スルフイド化合物である酸化型グルタチオンは、
対照である肝ホモジネートのみの場合と誘導期、
阻害率ともに全く乃至は殆んど変わらずチロシナ
ーゼに対する直接的な阻害作用は認められなかつ
た。一方、本発明に係るパンテチン及びパンテチ
ンアシル化誘導体は、誘導期を有意に遅延させる
と共に、反応初速度を大幅に低下させることによ
りチロシナーゼ活性を阻害し、メラニン生成過程
における中間体ドーパークロームの生成を低下さ
せることが実証された。
同様に、本発明の美白化粧料を用い色白効果、
シミ、ソバカスの改善効果を検討し、併せて従来
の美白化粧料と比較した。適用方法としては、色
黒、シミ、ソバカスに悩む32〜48才の女性30名を
選び、これらを無作為に3群(各10名)に分け、
第1群には後記実施例1の美白化粧水を、第2群
には実施例1中のジブタノイルパンテチンを酸化
型グルタチオンに置き換えた美白化粧水を、また
第3群には実施例1中のジブタノイルパンテチン
を除去(水を増量)したコントロールの化粧水
を、それぞれ1日につき朝、昼、晩の3回、3ケ
月間継続して使用してもらい、色黒、シミ、ソバ
カスの改善状態を3ケ月後に報告させた。
その結果を第2表に示す。[Table] As shown in the results in Table 1, calcium pantothenate, a precursor of pantethine, and oxidized glutathione, a disulfide compound,
Control liver homogenate alone and lag phase;
There was no or almost no change in the inhibition rate, and no direct inhibitory effect on tyrosinase was observed. On the other hand, pantethine and pantethine acylated derivatives according to the present invention inhibit tyrosinase activity by significantly delaying the induction period and significantly lowering the initial reaction rate, thereby inhibiting the production of intermediate doperchrome in the melanin production process. It has been demonstrated that it reduces Similarly, the skin whitening effect using the whitening cosmetic of the present invention,
We investigated its effectiveness in improving age spots and freckles, and compared it with conventional whitening cosmetics. The method of application was to select 30 women between the ages of 32 and 48 who suffer from dark skin, age spots, and freckles, and randomly divide them into three groups (10 women each).
The first group uses the whitening lotion of Example 1 described below, the second group uses the whitening lotion in which dibutanoyl pantethine in Example 1 is replaced with oxidized glutathione, and the third group uses Example 1. A control lotion with dibutanoyl pantethine removed (increased amount of water) was used three times a day in the morning, noon, and evening for three months. The subjects were asked to report their improvement status after three months. The results are shown in Table 2.
【表】
以上詳述した如く、本発明は生体活性に優れた
パンテチンおよびそのアシル化誘導体を効果的に
配合した美白化粧料に関するものであり、従来知
られている各種アスコルビン酸類、過酸化水素、
グルタチオン、コロイド硫黄等の美白物質等にチ
シロナーゼ活性阻害およびメラニン色素脱色作用
の点において同様の作用機序を有するグルタチオ
ンを配合した美白化粧料よりはるかに皮膚の色を
白くする効果があると共に何らの弊害もなく安全
に用いることができるものである。
次に本発明の美白化粧料の実施例を示す。配合
割合は重量部である。
実施例1 美白化粧水
エタノール 10.0
プロピレングリコール 5.0
ポリオキシエチレン(50)水添ヒマシ油
0.5
クエン酸 0.015
クエン酸ナトリウム 0.1
メチルパラベン 0.05
ジブタノイルパンテチン 1.0
香 料 0.4
水 83.0
実施例2 美白化粧オイル
スクワラン 49.9
ヒマシ油 49.9
トリ―2―エチルヘキサノイルパンテチン
0.3
ジブチルヒドロキシトルエン 0.01
香 料 0.3
実施例3 美白パツク
ポリビニルアルコール 20.0
エタノール 20.0
ジプロピオロイルパンテチン 1.0
グリセリン 5.0
香 料 0.5
水 53.5
実施例4 二層タイプ美白化粧水
Aエタノール
1,3―ブチレングリコール 15.0
4.0
B流動パラフイン
ミリスチン酸イソプロピル
トリデカノイルパンテチン 5.0
1.0
0.5
C香 料
メチルパラベン
δ―トコフエロール
パンテチン
水 0.4
0.1
0.1
0.5
74.4
実施例5 美白クリーム
Aステアリン酸
ゲイロウ
セタノール
ラノリン
ミリスチン酸イソプロピル
スクワラン
オリーブ油
トリ―2―エチルヘキサノイル
パンテチン
モノステアン酸ポリオキシエチレン
ソルビタン
モノステアン酸ソルビタン 8.0
4.0
4.0
2.0
6.0
7.0
2.0
0.7
5.0
1.0
Bプロピレングリコール
ブチルパラベン
メチルパラベン
ジブチルヒドロキシトルエン
パンテチン
香 料
水 5.0
0.1
0.1
0.05
0.1
0.3
54.5
実施例6 美白化粧水
エタノール 7.0
プロピレングリコール 5.0
ポリオキシエチレン(50)硬化ヒマシ油
0.5
クエン酸 0.02
クエン酸ナトリウム 0.1
メチルパラベン 0.05
δ―トコフエロール 0.2
パンテチン 0.3
香 料 0.4
水 87.0[Table] As detailed above, the present invention relates to a whitening cosmetic that effectively contains pantethine with excellent bioactivity and its acylated derivative.
It is far more effective at whitening the skin than skin whitening cosmetics containing glutathione, which has a similar mechanism of action in terms of inhibiting tisilonase activity and depigmenting melanin pigments, with whitening substances such as glutathione and colloidal sulfur. It can be used safely without any harmful effects. Next, examples of the whitening cosmetic composition of the present invention will be shown. The blending ratio is in parts by weight. Example 1 Whitening lotion ethanol 10.0 Propylene glycol 5.0 Polyoxyethylene (50) hydrogenated castor oil
0.5 Citric acid 0.015 Sodium citrate 0.1 Methylparaben 0.05 Dibutanoylpantethine 1.0 Fragrance 0.4 Water 83.0 Example 2 Whitening cosmetic oil Squalane 49.9 Castor oil 49.9 Tri-2-ethylhexanoylpantethine
0.3 Dibutylhydroxytoluene 0.01 Fragrance 0.3 Example 3 Whitening pack Polyvinyl alcohol 20.0 Ethanol 20.0 Dipropioloylpantethine 1.0 Glycerin 5.0 Fragrance 0.5 Water 53.5 Example 4 Two-layer type whitening lotion A Ethanol 1,3-butylene glycol 15.0 4.0 B Liquid paraffin Isopropyl tridecanoyl pantethine myristate 5.0 1.0 0.5 C Fragrance Methylparaben δ-Tocopherol Pantethine Water 0.4 0.1 0.1 0.5 74.4 Example 5 Whitening cream A Stearic acid Geirocetanol Lanolin Myristate Isopropyl squalane Olive oil Tri-2-ethyl hexa Noylpantethine monostearate polyoxyethylene sorbitan monostearate sorbitan 8.0 4.0 4.0 2.0 6.0 7.0 2.0 0.7 5.0 1.0 B Propylene glycol butyl paraben methyl paraben dibutyl hydroxytoluene Pantethine fragrance water 5.0 0.1 0.1 0.05 0.1 0.3 54.5 Example 6 whitening makeup Water Ethanol 7.0 Propylene Glycol 5.0 Polyoxyethylene (50) Hydrogenated Castor Oil
0.5 Citric acid 0.02 Sodium citrate 0.1 Methylparaben 0.05 δ-tocopherol 0.2 Pantethine 0.3 Fragrance 0.4 Water 87.0
Claims (1)
または一般式()で示されるパンテチンアシル
化誘導体を化粧料全体に対して0.01〜1重量%の
範囲で配合することを特徴とする美白化粧料。 一般式() 一般式() (式中、R1,R2,R3,R4は、すべて水素原子
又はすべてアシル基の場合を除くことを条件とし
て、少なくとも一つが炭素数2から10の直鎖また
は分岐鎖のアシル基でその他は水素原子を表わ
す。)[Claims] 1. Pantethine represented by the general formula () and/or
Alternatively, a whitening cosmetic comprising a pantethine acylated derivative represented by the general formula () in an amount of 0.01 to 1% by weight based on the total cosmetic. General formula () General formula () (In the formula, at least one of R 1 , R 2 , R 3 , and R 4 is a linear or branched acyl group having 2 to 10 carbon atoms, unless all are hydrogen atoms or all acyl groups.) (Others represent hydrogen atoms.)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15036379A JPS5673012A (en) | 1979-11-20 | 1979-11-20 | Beautifying cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15036379A JPS5673012A (en) | 1979-11-20 | 1979-11-20 | Beautifying cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5673012A JPS5673012A (en) | 1981-06-17 |
| JPS6320205B2 true JPS6320205B2 (en) | 1988-04-26 |
Family
ID=15495349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15036379A Granted JPS5673012A (en) | 1979-11-20 | 1979-11-20 | Beautifying cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5673012A (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5735511A (en) * | 1980-08-12 | 1982-02-26 | Sogo Yatsukou Kk | Dermatic medicine for external application |
| JPS58128310A (en) * | 1982-01-28 | 1983-07-30 | Dai Ichi Seiyaku Co Ltd | Skin conditioner |
| JPS58134022A (en) * | 1982-02-04 | 1983-08-10 | Dai Ichi Seiyaku Co Ltd | Remedy for hyperpigmentation |
| JPS6064922A (en) * | 1983-09-21 | 1985-04-13 | Sogo Yatsukou Kk | Dermatic drug for external application |
| JPH07238010A (en) * | 1994-02-24 | 1995-09-12 | Kanebo Ltd | Skin cosmetic |
| JP2005194203A (en) * | 2003-12-26 | 2005-07-21 | Dai Ichi Seiyaku Co Ltd | Bleaching composition |
| WO2006003965A1 (en) * | 2004-06-30 | 2006-01-12 | Daiichi Sankyo Healthcare Co., Ltd. | Skin-whitening compositions |
| EP2476408A4 (en) * | 2009-09-11 | 2013-03-06 | Daiichi Fine Chem Co Ltd | External preparation containing pantethine phosphate ester |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3285818A (en) * | 1964-05-07 | 1966-11-15 | Dauchi Seiyaku Kabushiki Kaish | Hair and skin compositions containing pantethine |
| JPS5279032A (en) * | 1975-12-24 | 1977-07-02 | Sunstar Inc | Crude drug compound |
| JPS54160315A (en) * | 1978-06-05 | 1979-12-19 | Dai Ichi Seiyaku Co Ltd | Ester of pantethine fatty acid |
-
1979
- 1979-11-20 JP JP15036379A patent/JPS5673012A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5673012A (en) | 1981-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68902353T2 (en) | SKIN DEPIGMENTATION AGENT. | |
| KR100308330B1 (en) | Aminophenol derivatives and their use in cosmetics | |
| JPS6391313A (en) | Medicine and antiacne cosmetic composition | |
| CH666679A5 (en) | RETINOICALLY ACTING NAPHTHALENIC DERIVATIVES, THEIR PREPARATION METHODS AND DRUG AND COSMETIC COMPOSITIONS CONTAINING THEM. | |
| JPS61155302A (en) | Skin color-lightening cosmetic | |
| CA1313372C (en) | Polycyclic heterocyclic derivatives, a process for their preparation and their application to veterinary and human medicine | |
| JPH022848B2 (en) | ||
| CH662559A5 (en) | 2,6-DISUBSTITUTED NAPHTHALENE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING THEM. | |
| JPH05294821A (en) | Cosmetic or dermatological composition containing 2,5-dihydroxyphenylcarboxylic acid, homolog or salt thereof as active ingredient and having depigmenting action | |
| CA2147807C (en) | Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses | |
| JPS6391362A (en) | Unsaturated aromatic peroxides and their use in therapeutic agents and cosmetics | |
| FR2746101A1 (en) | BICYCLIC-AROMATIC COMPOUNDS | |
| BE1000427A4 (en) | Benzofuran DERIVATIVES, METHODS OF PREPARATION AND DRUG COMPOSITIONS AND COSMETICS CONTAINING. | |
| JPS6344123B2 (en) | ||
| JPH11116425A (en) | Use of oxamate derivatives as depigmenting agents | |
| JPS6320205B2 (en) | ||
| EP0728739B1 (en) | Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations | |
| US5399785A (en) | Tyrosinase activity inhibitor | |
| JP3001834B2 (en) | Depigmenting agent comprising N, N'-dibenzylethylenediamine-N, N'-diacetate derivative | |
| JP3340935B2 (en) | Melanin production inhibitor and whitening cosmetic | |
| EP0819692B1 (en) | Kojic acid derivative as depigmentation agent | |
| JPH09176138A (en) | Novel L-2-oxothiazolidine-4-carboxylic acid derivative and its use for skin care | |
| JPH0656641A (en) | Cosmetics | |
| CA2003595A1 (en) | Use of diorganopolysiloxanes as anti-oxidative agents in cosmetics and dermatology | |
| JPH0114202B2 (en) |